227 related articles for article (PubMed ID: 12925502)
1. Assessing the diagnostic accuracy of a sequence of tests.
Thompson ML
Biostatistics; 2003 Jul; 4(3):341-51. PubMed ID: 12925502
[TBL] [Abstract][Full Text] [Related]
2. [ROC (receiver operating characteristics) curve: principles and application in biology].
Delacour H; Servonnet A; Perrot A; Vigezzi JF; Ramirez JM
Ann Biol Clin (Paris); 2005; 63(2):145-54. PubMed ID: 15771972
[TBL] [Abstract][Full Text] [Related]
3. [Receiver operating curve, an aid in decision making. Principles and applications illustrated with some examples].
Vinatier D; Monnier JC
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):981-9. PubMed ID: 3069898
[TBL] [Abstract][Full Text] [Related]
4. The agreement chart as an alternative to the receiver-operating characteristic curve for diagnostic tests.
Bangdiwala SI; Haedo AS; Natal ML; Villaveces A
J Clin Epidemiol; 2008 Sep; 61(9):866-74. PubMed ID: 18687288
[TBL] [Abstract][Full Text] [Related]
5. Combining biomarkers to detect disease with application to prostate cancer.
Etzioni R; Kooperberg C; Pepe M; Smith R; Gann PH
Biostatistics; 2003 Oct; 4(4):523-38. PubMed ID: 14557109
[TBL] [Abstract][Full Text] [Related]
6. Best combination of multiple diagnostic tests for screening purposes.
Qin J; Zhang B
Stat Med; 2010 Dec; 29(28):2905-19. PubMed ID: 20862668
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
Etzioni R; Falcon S; Gann PH; Kooperberg CL; Penson DF; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1640-5. PubMed ID: 15466981
[TBL] [Abstract][Full Text] [Related]
8. Receiver operating characteristics of the prostate specific antigen test in an unselected population.
McLernon DJ; Donnan PT; Gray M; Weller D; Sullivan F
J Med Screen; 2006; 13(2):102-7. PubMed ID: 16792835
[TBL] [Abstract][Full Text] [Related]
9. A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves.
Li CR; Liao CT; Liu JP
Stat Med; 2008 May; 27(10):1762-76. PubMed ID: 17968858
[TBL] [Abstract][Full Text] [Related]
10. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A
Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825
[TBL] [Abstract][Full Text] [Related]
11. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer.
Ashley T
J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948
[TBL] [Abstract][Full Text] [Related]
12. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
13. Serum prostate-specific antigen screening for prostate cancer: application of current evidence to model criteria.
Patel SH
Appl Health Econ Health Policy; 2003; 2(2):79-83. PubMed ID: 14619278
[TBL] [Abstract][Full Text] [Related]
14. Semi-parametric ROC regression analysis with placement values.
Cai T
Biostatistics; 2004 Jan; 5(1):45-60. PubMed ID: 14744827
[TBL] [Abstract][Full Text] [Related]
15. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
16. [Prostate cancer and prostate specific antigen screening].
Camici M
Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
[TBL] [Abstract][Full Text] [Related]
17. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.
Roddam AW; Hamdy FC; Allen NE; Price CP;
BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.
Sun L; Moul JW; Hotaling JM; Rampersaud E; Dahm P; Robertson C; Fitzsimons N; Albala D; Polascik TJ
BJU Int; 2007 Apr; 99(4):753-7. PubMed ID: 17244286
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of the performance characteristics of the free prostate-specific antigen test.
Lee R; Localio AR; Armstrong K; Malkowicz SB; Schwartz JS;
Urology; 2006 Apr; 67(4):762-8. PubMed ID: 16600352
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic tests: a statistical review.
Schulzer M
Muscle Nerve; 1994 Jul; 17(7):815-9. PubMed ID: 8008012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
